LFCR

Handel nachbörslich: 4.80

Lifecore Biomedical Inc (LFCR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1111)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

LFCR's Discussions on Twitter

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LFCR Lifecore Biomedical Inc	4.80	184.92M	147.12M	-33.88M	2.63M	-1.0623
TAK Takeda Pharmaceutical Co Adr	15.87	51.34B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.24	41.15B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.61	39.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	80.23	34.09B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	578.43	24.13B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-17	Hochstufung	Barrington Research	Mkt Perform → Outperform
2025-09-04	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-05-21	Eingeleitet	William Blair	Outperform
2024-09-05	Eingeleitet	Craig Hallum	Buy
2024-08-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2023-03-20	Herabstufung	Stephens	Overweight → Equal-Weight

Alle ansehen

Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten

LFCR Q1 2026 Earnings: Wider Loss Than Expected Despite Positive Stock ReactionGlobal Trading Community - Newser

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference - Sahm

LFCR Stock Price, Quote & Chart | LIFECORE BIOMEDICAL INC (NASDAQ:LFCR) - ChartMill

Lifecore CEO, CFO to meet investors at June 2-4 Chicago conference - Stock Titan

Lifecore Biomedical (LFCR) Q1 2026 Earnings Miss by Significant: Key TakeawaysCollaborative Trading Signals - Newser

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus

Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift - MSN

Lifecore reaffirms 2026 guidance of $120M-$125M revenue and $20.5M-$25M adjusted EBITDA while targeting 12% revenue CAGR by 2029 - MSN

Lifecore Biomedical to Participate at CDMO Live Europe - The Manila Times

TradingKey - TradingKey

The sustainable advantages Lifecore Biomedical (LFCR) is developing (+0.42%) 2026-05-10Fast Rising Stocks - newser.com

Number of shareholders of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN

LFCR Lifecore Biomedical shares slide 3.83% as Q1 2026 earnings miss estimates by 75.7% despite modest revenue growth.Social Momentum Signals - newser.com

The steady strength in Lifecore Biomedical (LFCR) story (Softens) 2026-05-08Company Analysis - newser.com

Lifecore Biomedical Q1 2026 Earnings Call Transcript - Sahm

Barrington Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Maintains Target Price $6 - Moomoo

MSN Money - MSN

Lifecore Biomedical: Q1 Earnings Snapshot - theheraldreview.com

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

Lifecore Biomedical, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LFCR) 2026-05-06 - Seeking Alpha

Lifecore Biomedical Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Keybanc Initiates Coverage of Lifecore Biomedical (LFCR) with Sector Weight Recommendation - MSN

Lifecore Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Lifecore Biomedical Q1 Earnings Call Highlights - Yahoo Finance

LFCR: Revenue fell 34% in Q1 2026, but cost controls and new programs support reaffirmed 2026 guidance - TradingView

Lifecore Biomedical 1Q 2026: Revenue $23.19M, EPS ($0.43) — 10-Q Summary - TradingView

Lifecore (NASDAQ: LFCR) posts 34% revenue drop and high debt load - Stock Titan

Lifecore Biomedical (LFCR) Q1 2026 revenue drops but 2026 outlook reaffirmed - Stock Titan

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update - The Manila Times

Lifecore Biomedical Q1 revenue falls 34%, misses analyst estimates - TradingView

Lifecore lands 3 new transfer programs while cutting operating costs - Stock Titan

Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 - The Manila Times

Before the bell May 6, Lifecore releases Q1 results, holds 8 a.m. webcast - Stock Titan

Barrington Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Raises Target Price to $6 - Moomoo

Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR) - Insider Monkey

[DEF 14A] LIFECORE BIOMEDICAL, INC. DE Definitive Proxy Statement - Stock Titan

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie LFCR